161 related articles for article (PubMed ID: 36788565)
21. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
22. A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning.
Tian L; Long F; Hao Y; Li B; Li Y; Tang Y; Li J; Zhao Q; Chen J; Liu M
Front Med (Lausanne); 2022; 9():880326. PubMed ID: 35479936
[TBL] [Abstract][Full Text] [Related]
23. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
Wu S; Zang Q; Dai B
Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
[TBL] [Abstract][Full Text] [Related]
24. An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.
Chen L; Wen Y; Xiong J; Chen Y; Chen CB
Biomed Res Int; 2023; 2023():1189022. PubMed ID: 36704723
[TBL] [Abstract][Full Text] [Related]
25. MMP25 Regulates Immune Infiltration Level and Survival Outcome in Head and Neck Cancer Patients.
Liang Y; Guan C; Li K; Zheng G; Wang T; Zhang S; Liao G
Front Oncol; 2020; 10():1088. PubMed ID: 32850314
[No Abstract] [Full Text] [Related]
26. A new pyroptosis model can predict the immunotherapy response and immune microenvironment characteristics and prognosis of patients with cutaneous melanoma based on TCGA and GEO databases.
Wang YY; Shi LY; Zhu ZT; Wang QJ
Ann Transl Med; 2022 Mar; 10(6):353. PubMed ID: 35434038
[TBL] [Abstract][Full Text] [Related]
27. Characterization of m6A-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis.
Meng J; Huang X; Qiu Y; Yu M; Lu J; Yao J
Int J Gen Med; 2021; 14():5345-5361. PubMed ID: 34522131
[TBL] [Abstract][Full Text] [Related]
28. A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma.
Jiang L; Yang Y; Liu F; Ma M; Gao J; Sun L; Chen Y; Shen Z; Wu D
Front Cell Dev Biol; 2022; 10():859958. PubMed ID: 35399535
[No Abstract] [Full Text] [Related]
29. Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts.
Mazurkiewicz J; Simiczyjew A; Dratkiewicz E; Pietraszek-Gremplewicz K; Majkowski M; Kot M; Ziętek M; Matkowski R; Nowak D
Cell Commun Signal; 2022 May; 20(1):63. PubMed ID: 35538545
[TBL] [Abstract][Full Text] [Related]
30. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
31. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
Cheng T; Chen P; Chen J; Deng Y; Huang C
Front Genet; 2021; 12():809600. PubMed ID: 35069702
[TBL] [Abstract][Full Text] [Related]
32. Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases.
Bates AL; Pickup MW; Hallett MA; Dozier EA; Thomas S; Fingleton B
J Pathol; 2015 Apr; 235(5):773-83. PubMed ID: 25469981
[TBL] [Abstract][Full Text] [Related]
33. CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis.
Ye W; Luo C; Liu F; Liu Z; Chen F
Front Oncol; 2021; 11():634617. PubMed ID: 33680972
[TBL] [Abstract][Full Text] [Related]
34. KIF2C is a Biomarker Correlated With Prognosis and Immunosuppressive Microenvironment in Human Tumors.
Zhang X; Li Y; Hu P; Xu L; Qiu H
Front Genet; 2022; 13():891408. PubMed ID: 35685442
[TBL] [Abstract][Full Text] [Related]
35. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract][Full Text] [Related]
36. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
37. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
38. Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma.
Zhao Q; Wang Q; Wang T; Xu J; Li T; Liu Q; Yao Q; Wang P
Front Immunol; 2021; 12():765615. PubMed ID: 34858419
[TBL] [Abstract][Full Text] [Related]
39. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
Liu S; Geng R; Lin E; Zhao P; Chen Y
Front Genet; 2021; 12():602160. PubMed ID: 33732282
[TBL] [Abstract][Full Text] [Related]
40.
Zhang Q; Liu YJ; Li JP; Zeng SH; Shen H; Han M; Guo S; Liu SL; Zou X
J Inflamm Res; 2022; 15():3065-3082. PubMed ID: 35637872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
